LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 13 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 3. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 13 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 3. - Dataset (ID:20250)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

|<
<<
Previous
Page 2 of 166
Next
>>
>
26 to 50 of 4140 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Timepoint	Timepoint Unit	Mean Total Cell Count Before Treatment	Mean Total Cell Count After Treatment	Mean Total Control Cell Count	Mean Relative Cell Count	Mean Normalized Growth Rate Inhibition Value
BT-20	CP724714	0.12	uM	LJP5	72	hr	1097	3658	3846	0.9512	0.9453
BT-20	CP724714	3.33	uM	LJP5	72	hr	1097	2909	3846	0.7563	0.7133
BT-20	CP724714	10	uM	LJP5	72	hr	1097	2233	3846	0.5792	0.4746
BT-20	Alvocidib	0.12	uM	LJP6	72	hr	1097	613	3673	0.1671	-0.2836
BT-20	Alvocidib	0.37	uM	LJP6	72	hr	1097	611	3673	0.1664	-0.2853
BT-20	Seliciclib	0.04	uM	LJP5	72	hr	1097	3909	3846	1.0169	1.0188
BT-20	Seliciclib	0.12	uM	LJP5	72	hr	1097	3839	3846	0.9988	0.9980
BT-20	Seliciclib	1.11	uM	LJP5	72	hr	1097	3081	3846	0.8022	0.7706
BT-20	Seliciclib	3.33	uM	LJP5	72	hr	1097	2834	3846	0.7370	0.6889
BT-20	AT-7519	0.12	uM	LJP6	72	hr	1097	1875	3673	0.5105	0.3589
BT-20	AT-7519	0.37	uM	LJP6	72	hr	1097	832	3673	0.2262	-0.1485
BT-20	AT-7519	3.33	uM	LJP6	72	hr	1097	540	3673	0.1468	-0.3382
BT-20	AT-7519	10	uM	LJP6	72	hr	1097	529	3673	0.1442	-0.3420
BT-20	AZD7762	1.11	uM	LJP6	72	hr	1097	1307	3673	0.3559	0.1055
BT-20	AZD7762	3.33	uM	LJP6	72	hr	1097	750	3673	0.2042	-0.1962
BT-20	AZD8055	0.04	uM	LJP6	72	hr	1097	1423	3673	0.3873	0.1601
BT-20	AZD8055	0.12	uM	LJP6	72	hr	1097	1170	3673	0.3188	0.0367
BT-20	AZD8055	3.33	uM	LJP6	72	hr	1097	906	3673	0.2468	-0.1038
BT-20	AZD8055	10	uM	LJP6	72	hr	1097	119	3673	0.0326	-0.7198
BT-20	Sorafenib	0.12	uM	LJP6	72	hr	1097	3487	3673	0.9497	0.9413
BT-20	Sorafenib	0.37	uM	LJP6	72	hr	1097	3050	3673	0.8306	0.7963
BT-20	CP466722	0.12	uM	LJP5	72	hr	1097	4048	3846	1.0535	1.0582
BT-20	CP466722	0.37	uM	LJP5	72	hr	1097	3786	3846	0.9853	0.9837
BT-20	GW843682X	0.12	uM	LJP6	72	hr	1097	2174	3673	0.5918	0.4792
BT-20	GW843682X	0.04	uM	LJP6	72	hr	1097	3006	3673	0.8188	0.7820

|<
<<
Previous
Page 2 of 166
Next
>>
>
26 to 50 of 4140 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 13 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 3. - Dataset (ID:20250)